Showing 1 posts of 1 posts found.
New and expensive treatments have driven up NHS prescribing costs in English hospitals, according to a new report. IMS Health …
EnteroBiotix appoints former GSK Chief Medical Officer to board
Stryker invests US$400m in CMR Surgical and secures option to acquire business
AI: an early warning system for patient safety
Tezspire improves symptoms and tissue inflammation in phase 3 EoE trial
Highlighting the value of lab research for healthcare innovation